Scarborough Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-263
Closed -$129K 636
2026
Q1
$129K Buy
+263
New +$143K 0.01% 168
2025
Q2
Sell
-589
Closed -$293K 498
2025
Q1
$293K Sell
589
-943
-62% -$511K 0.04% 103
2024
Q4
$797K Sell
1,532
-21
-1% -$11.5K 0.11% 71
2024
Q3
$961K Buy
+1,553
New +$919K 0.16% 51
2024
Q1
Sell
-1,593
Closed -$846K 695
2023
Q4
$846K Hold
1,593
0.17% 49
2023
Q3
$806K Buy
1,593
+8
+0.5% +$4.26K 0.2% 46
2023
Q2
$827K Buy
1,585
+24
+2% +$13K 0.2% 43
2023
Q1
$900K Sell
1,561
-44
-3% -$24.8K 0.23% 47
2022
Q4
$884K Sell
1,605
-40
-2% -$21.2K 0.24% 42
2022
Q3
$834K Hold
1,645
0.26% 43
2022
Q2
$894K Buy
1,645
+865
+111% +$476K 0.3% 41
2022
Q1
$461K Sell
780
-6
-0.8% -$3.45K 0.15% 43
2021
Q4
$524K Buy
+786
New +$491K 0.18% 42

Other funds holding TMO

Scarborough Advisors's TMO Position: Q2 2026 in Review

Scarborough Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 263 shares — an estimated $129K sold.

Scarborough Advisors first reported a position in TMO in Q4 2021 and held it in 13 quarters. The position peaked at $961K in Q3 2024. 627 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Scarborough Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Scarborough Advisors sold 263 Thermo Fisher Scientific shares in Q2 2026, an estimated $129K.
  • Scarborough Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 13 quarters.
  • Scarborough Advisors's Thermo Fisher Scientific position peaked at $961K in Q3 2024.
  • 627 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.